|Articles|October 8, 2015

Christian J. Nelson on Quality of Life Among Patients With Cancer

Christian J. Nelson, clinical psychologist, Memorial Sloan Kettering Cancer Center, discusses how quality of life changes over time and cancer's effect.

Newsletter

Stay up to date on cancer updates, research and education

Subscribe Now!

Related Content

In a recent interview with CURE, Dr. Kai Tsao discussed treatment advancements for patients with prostate cancer.

Breaking Down the Prostate Cancer Treatment Renaissance

ByDr. Kai Tsao

December 9th 2025

Dr. Robert Orlowski, chairman, Ad Interim; director of Myeloma; and professor of Medicine in the Departments of Lymphoma/Myeloma and Experimental Therapeutics within the Division of Cancer Medicine at the University of Texas MD Anderson Cancer Center in Houston.

Single-Drug Approach Explored for Newly Diagnosed Multiple Myeloma

ByDr. Robert Orlowski

December 8th 2025

Real-Time Text Tool Tracks Quality of Life in Myeloma Care

ByDr. James Berenson

December 7th 2025

Dr. Thomas Marron explains how therapeutic vaccines differ from preventative vaccines in lung cancer care.

How Therapeutic Vaccines May Transform Lung Cancer Care

ByDr. Thomas Marron

December 5th 2025

How Bispecific Antibodies Work to Treat Patients With Multiple Myeloma

ByDr. Amany Keruakous

December 5th 2025

Christian J. Nelson on Quality of Life Among Patients With Cancer

Newsletter

Related Content

Breaking Down the Prostate Cancer Treatment Renaissance

Single-Drug Approach Explored for Newly Diagnosed Multiple Myeloma

Real-Time Text Tool Tracks Quality of Life in Myeloma Care

How Therapeutic Vaccines May Transform Lung Cancer Care

How Bispecific Antibodies Work to Treat Patients With Multiple Myeloma

Trending on CURE

Real-Time Text Tool Tracks Quality of Life in Myeloma Care

Breaking Down the Prostate Cancer Treatment Renaissance

Tecvayli Treatment Combo Improves Outcomes in Relapsed/Refractory Myeloma

A Closet Full of Boobs and the Thought That Caught Me by Surprise

New Data Support Pelabresib Combination in Untreated Myelofibrosis